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Abstract
Phage-assisted continuous evolution (PACE) uses a modified filamentous bacteriophage life cycle
to dramatically accelerate laboratory evolution experiments. In this work we expand the scope and
capabilities of the PACE method with two key advances that enable the evolution of biomolecules
with radically altered or highly specific new activities. First, we implemented small molecule-
controlled modulation of selection stringency that enables otherwise inaccessible activities to be
evolved directly from inactive starting libraries through a period of evolutionary drift. Second, we
developed a general negative selection that enables continuous counter-selection against undesired
activities. We integrated these developments to continuously evolve mutant T7 RNA polymerase
enzymes with ∼10,000-fold altered, rather than merely broadened, substrate specificities during a
single three-day PACE experiment. The evolved enzymes exhibit specificity for their target
substrate that exceeds that of wild-type RNA polymerases for their cognate substrates, while
maintaining wild-type-like levels of activity.
Introduction
During phage-assisted continuous evolution (PACE), a population of bacteriophage, each
encoding a library member of an evolving gene, selectively replicates in a “lagoon” of
continuously replenished E. coli host cells in a manner that depends on an activity of interest
(Figure 1).1 These selection phage (SP) lack gene III, which has been moved from the phage
genome to an accessory plasmid (AP) carried by the host cells. Gene III encodes the phage
protein pIII, which is essential for infectious phage production.2 Expression of pIII from the
AP is made dependent on the activity of interest, such that only SP encoding active library
members induce expression of pIII and the production of infectious progeny phage. A
mutagenesis plasmid (MP) enables small-molecule control over the mutation rate during
phage replication. Infectious progeny phage can infect fresh host cells flowing into the
lagoon and thereby continue to undergo additional cycles of selection, replication, and
mutation. Because one complete cycle of phage replication can be as brief as 10 minutes,3
PACE enables hundreds of rounds of directed evolution to take place in less than a week
with minimal researcher intervention, representing a ∼100-fold increase in speed over
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ttraditional protein evolution methods.4,5 We previously used PACE to evolve T7 RNA
polymerase (RNAP) mutants that initiate transcription at the T3 promoter (PT3), which
differs from the T7 promoter (PT7) at six of 17 base positions.1,6,7 Though successful, our
early PACE efforts highlighted two major needs.
First, when we challenged wild-type T7 RNAP to evolve activity directly on PT3, active
mutants did not emerge and the phage in the lagoon washed out, indicating that the
stringency of this initial selection was too high.1,6,7 The successful evolution of activity on
PT3 instead required initial selection on a hybrid T7/T3 promoter (PT7/T3) that served as an
evolutionary stepping-stone toward the PT3 selection. For many potential applications of
PACE, suitable intermediate substrates may not be obvious or accessible. To address this
limitation, we sought to develop a general modulator of selection stringency that can be
tuned simply by adding a small molecule to a lagoon. Initiating PACE under reduced
selection stringency in principle can allow weakly active or inactive variants to access
favorable mutations that enable propagation under subsequent higher-stringency selection
conditions.
Second, the T7 RNAPs evolved to recognize PT3 retained most or all of their activity on
PT7. In the absence of explicit negative selection against undesired activity, the evolution of
novel substrate recognition often results in enzymes with broadened, rather than truly altered
specificity.8,9 For many potential targets of PACE, including proteases, binding proteins,
and genome engineering enzymes, evolved proteins will require exceptional substrate
specificity to function in complex cellular environments containing many potential off-target
substrates. We therefore sought to develop a general negative selection for PACE in which
SPs encoding variants with undesired activities, such as off-target substrate recognition,
incur a replicative penalty.
In this study we developed robust and general solutions that address both of these needs.
Integrating these advances, we directly evolved in a single PACE experiment T7 RNAP
mutants that have wild-type like activity on PT3 and remarkable specificity for PT3 over PT7.
This evolved degree of specificity exceeds that of wild-type T7 RNAP for PT7 over PT3, as
well as that of wild-type T3 RNAP for PT3 over PT7. The combination of stringency
modulation and negative selection enabled the evolution of polymerases with ∼10,000-fold
changes in specificity in a total time of only three days. Together, these developments bring
to PACE two capabilities recognized to be highly enabling for laboratory evolution efforts.
These capabilities also expand the scope of PACE to include the evolution of biomolecules
that possess radically altered and highly specific new activities.
Results
Small Molecule-Controlled Selection Stringency Modulation
We hypothesized that selection stringency during PACE can be varied by providing host
cells with carefully regulated amounts of pIII in a manner independent of the desired
evolving activity. To create this capability, we placed expression of gene III on an AP under
the control of the small molecule-inducible TetA promoter (Ptet) and observed
anhydrotetracycline (ATc) concentration-dependent gene III expression and phage
production in a discrete host cell culture (Supplementary Results, Supplementary Figure 1).
To test propagation in a streamlined PACE format, we modified our original host cell
culture system to operate as a chemostat. Compared to host cell cultures maintained at
constant turbidity (turbidostats), cultures maintained at a constant nutrient flow rate
(chemostats) are simpler to set up and do not require constant turbidity monitoring. We
found that chemostats using E. coli S1030 cells support PACE comparably to turbidostats
cultures (data not shown), and therefore used chemostats for the PACE experiments in this
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tstudy. Although an AP containing Ptet-gene III supported ATc-dependent phage production
in a discrete host cell culture, this AP did not support robust phage propagation in a PACE
format when ATc was added to a lagoon (Figure 2a). Because even low levels of pIII render
cells resistant to filamentous phage infection,10 we hypothesized that these host cells, which
begin producing pIII soon after entering a lagoon, become phage infection-resistant prior to
encountering phage, thereby preventing phage propagation (Supplementary Figure 1).
To create a system in which activity-independent pIII expression requires both ATc and
prior phage infection, we used the previously described E. coli phage shock promoter (Ppsp),
which is induced by infection with filamentous phage via a pIV-dependent signaling
cascade.11 Transcription from Ppsp can also be induced by overexpression of a plasmid-
encoded phage pIV gene.12 Phage lacking gene III are known to form plaques on cells
containing a Ppsp-gene III cassette.13 We confirmed and extended this observation by
showing that an AP with this cassette supports robust propagation in a PACE format (Figure
2b).
To make phage propagation ATc-dependent, we examined the gene expression properties of
Ppsp variants with TetR operators installed at positions intended to disrupt either PspF or E.
coli RNA polymerase binding (Supplementary Figure 1). We found that placing an operator
adjacent to the +1 transcription initiation site creates a promoter (Ppsp-tet) that is induced
only with the combination of phage infection and ATc (Supplementary Figure 1).
Importantly, this AP supported robust ATc-dependent propagation of a SP without any
activity-dependent gene III expression (Figure 2c). High Ppsp-tet-gene III induction (200 ng/
mL ATc) supported propagation with dilution rates of 2.5 vol/h, corresponding to an average
of 30 phage generations per 24 hours. These results collectively demonstrate that SPs can
propagate in an ATc-dependent, activity-independent manner using the Ppsp-tet-gene III AP,
thus enabling selection stringency to be altered during PACE in a small molecule-regulated
manner.
Tuning Selection Stringency During PACE
Next we examined how the Ppsp-tet-gene III cassette influences the enrichment of active
library members over inactive library members in the context of an actual PACE selection in
which an additional copy of gene III is controlled by an activity-dependent promoter. At
saturating concentrations of ATc, the Ppsp-tet-gene III cassette should provide sufficient pIII
to maximize phage propagation regardless of SP-encoded activity, enabling genetic drift of
the SP. At intermediate concentrations of ATc, SPs encoding active library members should
enjoy a replicative advantage over a SP encoding an inactive variant by inducing additional
pIII expression from an activity-dependent promoter. This advantage, and therefore
selection stringency, should be inversely proportional to the concentration of ATc provided.
In the absence of any added ATc, selection stringency should be fully determined by the
activity-dependent AP components with no assistance from the Ppsp-tet-gene III cassette.
To characterize the relationship between ATc concentration and selection stringency, we
combined the Ppsp-tet-gene III cassette with the arabinose-inducible mutagenesis cassette1
onto a single “drift plasmid” continuously flowing host cells that contained both this DP and
an AP with a PT7-gene III cassette (Figure 2d). We then seeded lagoons with a mixture of
two SPs encoding either the highly active wild-type T7 RNAP (SP-T7WT) or the catalytic
dead mutant D812G (SP-T7Dead).14 These phage were added in a ratio of 1:100 SP-
T7WT:SP-T7Dead to each of three lagoons receiving either 0, 150, or 400 ng/mL ATc. The
phage populations were followed over time using a combination of restriction endonuclease
digests and real-time measurements of luminescence monitoring of PT7 transcriptional
activity.
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tAs expected, under the highest stringency conditions (0 ng/mL ATc), SP-T7Dead washed out
of the lagoon and the highly active SP-T7WT was quickly enriched (Figure 2e). At an
intermediate concentration of ATc (150 ng/mL), SP-T7Dead again washed out in favor of
SP-T7WT, but at a slower rate than in the absence of ATc (Figure 2f). At the highest
concentration of ATc (400 ng/mL), SP-T7Dead was able to propagate and no substantial
enrichment of the active SP-T7WT was observed (Figure 2g). When we stopped ATc
supplementation to this lagoon, we observed very rapid enrichment of SP-T7WT consistent
with the expected increase in stringency (Figure 2e). Taken together, these results establish
that Ppsp-tet-gene III supports propagation of inactive starting libraries in the presence of
high ATc concentrations, and supports the selective enrichment of active mutants at a rate
inversely proportional to the concentration of ATc added to the lagoon.
Development of a PACE Negative Selection
An ideal PACE negative selection inhibits infectious phage production in a manner that is
tunable and proportional to the ratio of undesired (off-target) to desired (on-target) activity,
rather that simply reflecting the absolute level of undesired activity. We therefore sought to
develop a negative selection in which undesired activity induces expression of a protein that
antagonizes the wild-type pIII induced in a positive selection.
The pIII protein consists of three domains, N1, N2, and C, that mediate initial attachment of
the phage to the E. coli F-pilus (N2 domain), subsequent docking with the E. coli TolA cell-
surface receptor (N1 domain), and unlocking of the particle for genome entry (C
domain).15,16 During progeny phage synthesis, five pIII molecules are attached by the C-
domain to the end of each nascent phage particle.17,18 A presumed conformational change in
this C-domain then catalyzes detachment of the nascent phage from the inner membrane,
thereby releasing the phage from the host cell.16
One pIII mutant described by Rakonjac and co-workers, N-C83, contains intact N1 and N2
domains but has a mutant C domain with an internal deletion of 70 amino acids.16 The
residual C domain is sufficient to mediate attachment to a phage particle, but cannot catalyze
detachment of nascent phage from the host cell membrane.16 When co-expressed with a pIII
variant containing only the intact C domain (which can mediate nascent phage detachment),
phage particle production was found to be normal, but the infectivity of these particles was
drastically reduced.16 These observations raised the possibility that N-C83 may function as a
dominant negative mutant of wild-type pIII.
To test the suitability of N-C83 as the basis for a PACE negative selection, we created a host
cell line containing an AP with a Ptet-gene III cassette induced by ATc, a second accessory
plasmid (APneg) with N-C83 driven by an IPTG-inducible promoter (Plac). Discrete host cell
cultures were grown in the presence or absence of ATc and IPTG, and culture broths were
assayed for infectious phage titer. As expected, the addition of ATc induced expression of
wild-type pIII and stimulated phage production (Supplementary Figure 2). The simultaneous
addition of IPTG, which induces N-C83 expression, dramatically reduced the titer of
infectious phage. This result suggests that N-C83 can act as a dominant negative form of
pIII. Alternative truncation candidates of pIII did not diminish infectious phage titer to the
same degree as N-C83 (Supplementary Figure 2). We also observed evidence to suggest that
N-C83 may inhibit infectious phage production by blocking the release of phage from the
host cell, rather than by reducing the infectivity of the released phage particles
(Supplementary Figure 3). These results reveal that expression of N-C83, hereafter referred
to as pIII-neg, can form the basis of a potent negative selection.
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tPACE Negative Selection Enriches Substrate-Specific RNAPs
Next we tested if this negative selection could enrich a substrate-specific T7 RNAP over a
promiscuous RNAP in the PACE format. For this competition experiment, we used SPs
encoding two RNAP variants that we recently described: L2-48.3 (specific for PT7,
expressed from SP-T7Spec) and L1-192.2 (active on both PT7 and PT3, expressed from SP-
T7Prom).1 We prepared a host cell strain containing both a positive selection AP (PT7-gene
III AP) and a negative selection AP (PT3-gene III-neg APneg) in which pIII-neg translation is
controlled by a theophylline-activated riboswitch (Figure 3a).19 During PACE with this host
cell strain, the propagation of SP-T7Prom should be impaired, relative to SP-T7Spec, in the
presence of theophylline.
Three lagoons containing these host cells were each seeded with a 106:1 ratio of SP-
T7Prom:SP-T7Spec and allowed to equilibrate for 4.5 hours. We treated the lagoons with 0,
75, or 1000 μM theophylline and followed the concentrations of the two SP species over
time. In the presence of 1000 μM theophylline, SP-T7Prom was rapidly depleted from the
lagoon and the SP-T7Spec population expanded dramatically into the predominant species
after only 6 hours of PACE (Figure 3b). Furthermore, the rate of enrichment was dependent
on the concentration of theophylline added to the lagoon, where lower concentrations of
theophylline resulted in slower enrichment rates (Figures 3c and 3d). These results
demonstrate that pIII-neg can serve as the basis of a potent and dose-dependent negative
selection that can effect the rapid enrichment of substrate-selective enzymes in a PACE
format.
PACE of RNAPs with Altered Promoter Specificities
We integrated both the tunable selection stringency and the negative selection developments
described above to rapidly evolve enzymes with dramatically altered substrate specificity
without the use of intermediate substrates. We prepared two lagoons with host cells
containing a PT3-gene III AP and the DP containing the Ppsp-tet-gene III cassette, and seeded
these lagoons with SP-T7WT, which has negligible starting activity on PT3. To one lagoon,
we added no ATc and observed that phage quickly washed out (data not shown), as
expected.1 To the second lagoon, we added 200 ng/mL ATc, which allowed even inactive
phage to propagate. After 12 hours (t = 12 h), the phage in this lagoon increased in
concentration dramatically, but still encoded RNAPs with negligible activity on PT3. We
then reduced the concentration of ATc to 20 ng/mL, thus increasing the selection stringency
for recognition of PT3 (Figure 4).
After an additional six hours of propagation in 20 ng/mL ATc (t = 18 h), a PT3-active
population overtook the lagoon as indicated by an increase in signal from the in-line
luminescence monitor. This signal continued to increase over the next 10 hours. RNAP
clones isolated from the 28-hour time point evolved an ∼100-fold increase in activity on PT3
(Figure 4) and converged on two mutations, E222K and N748D, that we1 and others20
previously found to broaden the substrate scope of T7 RNAP (Supplementary Figure 4).
These results demonstrate that selection stringency modulation can be used to directly
evolve a novel activity from an inactive starting gene without the use of intermediate
substrates as evolutionary stepping-stones, as was previously necessary to evolve T3
promoter recognition without selection stringency modulation.1
As expected, the RNAPs recovered from this stage of the selection still retained high activity
on PT7 (Figure 4). To initiate negative selection against recognition of PT7, we used host
cells containing the same PT3-gene III AP, the MP (lacking the drift cassette), and a PT7-
gene III-neg APneg in which pIII-neg expression is driven by PT7 transcription, and
controlled by a theophylline-dependent riboswitch (Figure 4). The 28-hour lagoon described
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tabove was divided into two new lagoons, each of which received these host cells for 4
hours. Theophylline was added to the first lagoon to activate the negative selection (t = 32
h), whereas the second lagoon did not receive any theophylline. After 24 hours (t = 52 h),
several RNAPs isolated from the first lagoon showed clear improvements in specificity for
PT3 (Figure 4) and contained a variety of mutations (Supplementary Figure 4) at residues
proximal to the promoter in the initiation complex and known to be relevant to substrate
selectivity. In contrast, clones isolated from the second lagoon, which did not receive
theophylline, did not show clear changes in specificity.
In an effort to further enhance the specificity of the evolving RNAPs, we increased the
stringency of the negative selection in two ways. First, we weakened the ribosome binding
site driving translation of pIII from the AP, with the expectation that evolved RNAPs would
compensate with increased (but still PT3-selective) transcriptional activity. Second, we
installed a high-copy pUC origin into APneg, and replaced the theophylline riboswitch with a
very strong ribosome-binding site driving pIII-neg translation (Figure 4). Together, these
modifications should increase the stringency of the negative selection by increasing the ratio
of pIII-neg to pIII produced for a given ratio of PT7:PT3 activity.
The phage population from the previous stage (t = 52 h) was transferred to lagoons fed by
these high-stringency host cells and a substantial decline and rebound of the phage
population was observed (Figure 4). Evolved RNAPs isolated following this recovery (t =
70 h) exhibited dramatically improved specificity for PT3 over PT7 of up to 100-fold and
strongly converged on mutations observed in the previous stage (R96L, K98R, E207K,
P759S/L) (Figure 4 and Supplementary Figure 4). A forward mutational analysis of these
mutations in the E222K/N748D background highlighted the role of each of these changes in
conferring strong specificity for PT3 (Figure 5). The degree of specificity evolved using
stringency control and negative selection PACE rivals or exceeds that of naturally occurring
wild-type T7 or T3 RNA polymerase enzymes; for example, wild-type T7 RNAP exhibits a
PT7:PT3 activity ratio of ∼100-fold, and wild-type T3 RNAP exhibits a PT3:PT7 activity
ratio of ∼20-fold (Figure 5). Compared to the wild-type T7 RNAP enzyme, the most PT3-
specific evolved RNAP clones exhibited a net ∼10,000-fold change in specificity for PT3.
Importantly, this remarkable degree of specificity did not evolve at the expense of activity,
and all assayed clones retained levels of transcriptional activity on PT3 that are comparable
to or higher than that of wild-type T7 RNAP on its cognate T7 promoter (Figure 4).
Collectively, these results establish that the PACE negative selection can be used to
explicitly evolve enzymes with truly altered, rather than broadened, specificity.
Discussion
Traditional directed evolution techniques, while valuable and successful, require frequent
researcher intervention throughout each round of mutation, screening or selection, and
replication to access biomolecules with desired properties. By mapping the essential
components of the directed evolution cycle onto the very rapid M13 filamentous
bacteriophage lifecycle, PACE can dramatically accelerate laboratory evolution. In this
work we have significantly expanded the capabilities of PACE by developing a general
strategy to modulate selection stringency—to zero if needed—with a small molecule, and by
developing a negative selection that links undesired activities to the inhibition of phage
propagation. Together, these capabilities were used to evolve RNA polymerase variants with
∼10,000-fold altered promoter specificity in a PACE experiment lasting only three days.
T7 RNA polymerases that evolved the ability to accept the T3 promoter and reject the T7
promoter acquired a suite of highly conserved mutations, including R96L, K98R, E207K,
E222K, N748D, and P759S/L. The mutations at positions 98 and 748 change each residue to
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tthe amino acid found in wild-type T3 RNAP, and the R96L mutation is at a position that
also differs between wild-type T7 and T3 RNAPs (although it is K96 in T3 RNAP). These
residues are predicted to be proximal to the promoter bases (Figure 5b), and their role in
promoter recognition has been previously appreciated.21 The occurrence of these mutations
in our selections suggests that the evolved mutants may use a mode of PT3-selective
promoter recognition similar to that of wild-type T3 RNAP at these positions. In contrast,
residues 207, 222, and 759 are conserved between T7 and T3 RNAPs, and the significant
role of mutations at these residues in conferring selectivity (particularly P759S/L, Figure 5a)
suggests the evolution of some novel determinants of promoter recognition that may not be
used by the native enzymes. E207 modestly increases selectivity for PT3 (Figure 5a) and is
within 4 Å of the RNAP specificity loop (residues 739-770), a major determinant of
promoter specificity22 that includes P759.
The negative selection uses a dominant negative variant of pIII, the protein that is the basis
of the positive selection of PACE, and does not rely on any property of the gene or gene
product being evolved. Therefore, we anticipate that the negative selection will be general in
its compatibility with a variety of activities that can be evolved using PACE, provided that
the selection scheme can link undesired activity to expression of pIII-neg (and not pIII). For
many potential proteins that can be evolved with PACE, including DNA-binding proteins,
recombinases, protein-protein interfaces, proteases, and other enzymes, a suitable dual
selection scheme can be created by localizing undesired substrates upstream of gene III-
neg.1 In most cases, such a negative selection can operate simultaneously with pIII-mediated
positive selection. Likewise, since the method to modulate selection stringency developed
here relies on providing pIII in a regulated manner that is also independent of the evolving
gene, this stringency modulation capability should also be applicable to other PACE
experiments.
Methods
Bacterial strains
All DNA cloning was performed with Mach1 cells (Invitrogen) or NEB Turbo cells (New
England Biolabs). All discrete infection assays, plaque assays and PACE experiments were
performed with E. coli S1030. This strain was derived from E. coli S1091 and was modified
using the Lambda Red method23 as follows: 1) scarless mutation to rpoZ to introduce a
frameshift mutation to enable n-hybrid schemes;24 2) integration of lacI and tetR
overexpression cassettes onto the F plasmid to enable small-molecule regulated transcription
of various genes; 3) integration of luxCDE onto the F plasmid for the production of decanal
to facilitate luciferase monitoring experiments;25 4) deletion of flu/pgaC/csgABCDEFG to
dramatically reduce biofilm formation in chemostat PACE experiments;26-28 and 5)
mutation of the chromosomal, low-affinity high-capacity AraE promoter to a constitutive
promoter for titratable arabinose induction of the PBAD promoter on the mutagenesis
plasmid.29 The complete genotype of the resulting strain is F'proA+B+ Δ(lacIZY)
zzf∷Tn10(TetR) lacIQ1 PN25-tetR luxCDE/endA1 recA1 galE15 galK16 nupG rpsL(StrR)
ΔlacIZYA araD139 Δ(ara,leu)7697 mcrA Δ(mrr-hsdRMS-mcrBC) proBA∷pir116 araE201
ΔrpoZ Δflu ΔcsgABCDEFG ΔpgaC λ−.
Chemostat growth media
Media for all chemostat PACE experiments was prepared by autoclaving a 20 L carboy of
MilliQ water containing a custom Davis rich media formulation: anhydrous K2HPO4 (140
g), KH2PO4 (40 g), (NH4)2SO4 (20 g), NaCl (58 g), casamino acids (100 g), Tween-80 (20
mL), L-cysteine (1 g), L-tryptophan (0.5 g), adenine (0.5 g), guanine (0.5 g), cytosine (0.5
g), uracil (0.5 g), CaCl2 (0.5 μM final). This was allowed to cool overnight, and
Carlson et al. Page 7
Nat Chem Biol. Author manuscript; available in PMC 2014 September 01.
H
H
M
I
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
H
H
M
I
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
H
H
M
I
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tsupplemented with a 500 mL filter-sterilized solution of MilliQ water containing: NaHCO3
(16.8g), glucose (90 g), sodium citrate (10 g), MgSO4 (1 g), FeSO4 (56 mg), thiamine (134
mg), calcium pantothenate (94 mg), para-aminobenzoic acid (54 mg), para-hydroxybenzoic
acid (54 mg), 2,3-dihydroxybenzoic acid (62 mg), (NH4)6Mo7 (3 nM final), H3BO3 (400
nM final), CoCl2 (30 nM), CuSO4 (10 nM final), MnCl2 (80 nM final), and ZnSO4 (10 nM
final). Cultures were supplemented with the appropriate antibiotics in the following final
concentrations: carbenicillin (AP; 50 μg/mL), spectinomycin (APneg; 50 μg/mL),
chloramphenicol (MP; 40 μg/mL). Streptomycin (for selection of S1030 cells carrying the
rpsL marker) and tetracycline (for selection of the F plasmid) were not routinely included in
culture media.
Real-time luminescence monitor
The in-line bioluminescence measurements were made by a modified luminometer. A
TD-20e luminometer (Turner Designs) was installed inside a dark box in continuous reading
mode. While in this mode, the luminometer outputs a DC voltage that varies between 0 and
4 V depending on the light level received by the photomultiplier fitted in the instrument (the
range was set to the most sensitive one). This signal was sent to an Arduino Mega (Arduino)
prototyping board through the analog input port. The Arduino board was controlled via
Matlab (Mathworks), using a custom Graphical User Interface (GUI). Measurements were
taken at around 100 Hz and then integrated to 1 s before being written by the software into a
text file. To allow for multichannel recordings, the system was fitted with a custom tube
holder that could hold up to four flow-through tubes with minimal cross talk between
channels. Because the holder allows for only one tube to be observed at a time, it is mounted
on a stepper motor that is in turn controlled using the Matlab GUI via the Arduino board and
a Pololu A4988 stepper motor driver (Pololu R&E). The system waits until a measurement
is complete before rotating the sample holder until the next tube is in position. The cycle
repeats until all channels are covered, then unwinds to start a new cycle. The time between
measurements of a particular channel is ∼30 s. Data analysis comprised temporal binning
and low-pass Fourier filtering of the raw traces.
Assay for infection-competence of recipient cells
Recipient cultures were grown to mid-log phase, and 100 μL of culture was mixed by
pipetting with 2 μL of pJC126b phagemid prep (encodes R6K origin, f1 origin, pLac-YFP)
totaling ∼109 cfu. Reactions were incubated for 2 min and then 1 μL of the reaction was
diluted into 1 mL of fresh 2xYT media. Cells were pelleted, resuspended in 1 mL fresh
2xYT, and an aliquot was diluted 10-fold into fresh media. 20 μL of the resulting media was
plated on 2xYT-agar plates with 1 mM IPTG and grown overnight. Colonies were scanned
on a Typhoon laser imager (488 nm laser, 520/40 filter).
Discrete assay for phage production
Cultures with candidate drift plasmids contained: pT7 (pJC173b), pTet (pJC148i2), psp
(pJC175e), psp-tet (pJC175g/h/k/m/n), psp-tet on MP (pJC184d5), psp-tet on colE1-spect
plasmid (pJC184d-Sp). Cultures were grown to mid-log phase in Davis rich media and
infected with an excess of SP-T7 for 10 min at 37°C. Cells were pelleted and washed to
remove residual excess phage. Cells were re-inoculated into fresh Davis rich media and
grown to OD600 ∼0.8, pelleted, and supernatants were saved for titering by plaque assay on
S1030 E. coli cells carrying a PT7-gene III AP (pJC173b).. OD600 values were measured to
normalize phage titers.
Cultures with candidate negative selection plasmids contained PTet-gene III (pJC148i2) and
either Plac-C-domain (pJC156a2), Plac-C83 (pJC156c2), Plac-N1-N2-C83 (pJC156j2), Plac-
N2-C83 (pJC156m2), or Plac-N1*-N2-C83 (pJC156o2). Cells were treated with SP-T7
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tphage as described above and then cultured in 2xYT media with either 4 ng/mL or 20 ng/mL
ATc and in the presence or absence of 2 mM IPTG. Phage titers were assayed as described
above.
Cultures for theophylline-dependent negative selection contained PT7-gene III (pJC173c)
and PT3-theophylline riboswitch-gene III-neg (pJC174c-R5). Cells were treated with either
SP-T7192.2 or SP-T748.3 and then cultured with varying concentrations of theophylline.
Phage titers were assayed as described above.
Continuous flow experiment of PTet-gene III drift cassette
A chemostat culture of S1030 cells carrying an AP encoding PTet-gene III (pJC148i2) was
prepared and growth was equilibrated overnight at a flow rate of 400 mL/h in a chemostat
volume of 250 mL. The next morning, two lagoons (40 mL each, flow rate from the
chemostat of 100 mL/h) were seeded with 107 pfu of SP-T7. Lagoons received supplements
delivered by syringe pump (flow rate 1 mL/h) consisting of either 20 μg/mL ATc (resulting
in 200 ng/mL final concentration) or water only. At 4-hour intervals, 0.6-mL samples were
taken from lagoons, measured discretely for luminescence, and centrifuged to remove cells.
Supernatants were combined with an equal volume of 50% glycerol and stored in the
freezer. Phage titers of supernatants were measured on S1030 cells containing an AP
encoding PT7-gene III (pJC173b).
Continuous flow experiment of Ppsp-gene III drift cassette
A chemostat culture of S1030 cells carrying an AP encoding Ppsp-gene III (pJC175e) was
prepared and equilibrated overnight. The flow rate was 400 mL/h in a chemostat volume of
250 mL. The next morning, a lagoon (40 mL each, flow rate 100 mL/h) was started and
seeded with 107 pfu of SP-T7WT. At 4-hour intervals, samples were taken and processed as
described above.
Continuous flow experiment of Ppsp-tet-gene III drift cassette
A chemostat culture of S1030 cells carrying plasmid Ppsp-tet-gene III (pJC175h) was
prepared equilibrated overnight. The flow rate was 400 mL/h in a chemostat volume of 250
mL. The next morning, two lagoons (40 mL each, flow rate 100 mL/h) were started and
seeded with 107 pfu of SP-T7WT. Lagoons received supplements delivered by syringe pump
(flow rate 1 mL/h) consisting of either 20 μg/mL ATc (resulting in 200 ng/mL final
concentration) or water only. At 4-hour intervals, samples were taken and processed as
described above.
Continuous flow experiment of Ppsp-tet-gene III drift cassette with ATc dose-dependent
stringency
A chemostat culture of S1030 cells carrying a DP encoding Ppsp-tet-gene III with a
mutagenesis cassette (pJC184d5) and an AP encoding PT7-6xHisTag-gene III (pJC173c)
was prepared and equilibrated overnight. The flow rate was 400 mL/h in a chemostat
volume of 250 mL. The next morning, three lagoons (40 mL each, flow rate 100 mL/h) were
started, with their waste lines diverted through the in-line luminescence monitor. Lagoons
were seeded with a mixture containing 109 pfu SP-T7Dead (D812G) and 107 pfu SP-T7WT,
along with ATc in an amount that brought the 40 mL lagoon to the target final ATc
concentration for each lagoon. Lagoons received supplements delivered by syringe pump
(flow rate 1 mL/h) consisting of either 15 μg/mL ATc (to make 150 ng/mL final
concentration), 40 μg/mL ATc (to make 400 ng/mL final concentration), or no ATc (water
only). At t = 8 h, the lagoon receiving 40 μg/mL ATc was switched to receive water only. At
timepoints t = 2, 4, 6, 8, and 16 h, 0.6-mL samples were taken from the lagoon, measured
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tindividually for luminescence, and centrifuged to remove cells. Supernatants were combined
with an equal volume of 50% glycerol and stored in the freezer.
Supernatants were analyzed for relative phage ratios using a PCR and analytical restriction
digestion. 1 μL of each supernatant was added to a 20 μL qPCR reaction (iQ SYBR Green
Mastermix, Biorad) with primers JC1480 (5′-TCCAGCACTTCTCCGCGATGCTC-3′) and
JC1481 (5′-GAAGTCCGACTCTAAGATGT CACGGAGGTTCAAG-3′) and amplified by
PCR with SYBR Green fluorescence monitored following each amplification cycle. Samples
were removed individually from the PCR block after exceeding a pre-determined
fluorescence threshold, and placed on ice. Samples were then quantitated again by SYBR
Green fluorescence in a plate reader, and approximately equal amounts of DNA from the
reactions (normalized based on the fluorescence readings) were added to restriction
digestion reactions. The digestion reactions used enzymes EcoRV and HindIII in buffer
NEB2 with BSA and were performed following the manufacturer's instructions in 20 μL
total volumes. Digestions were inactivated with heat, combined with 0.2 volumes of 5×
loading dye containing Orange G and xylene cyanol, and analyzed by agarose gel
electrophoresis (1% agarose, 0.5× TBE, 120V, 80 min). The electrophoresed gel was stained
with SYBR Gold (Invitrogen) and imaged on a Typhoon laser scanner (excitation 488,
emission 520/40 nm).
Continuous flow experiment of dose-dependent negative selection
A chemostat of S1030 host cells containing an AP encoding PT7-gene III (pJC173c) and an
APneg encoding PT3-theophylline riboswitch-gene III-neg (pJC174c-R5) was prepared and
equilibrated overnight at a flow rate of 400 mL/h in a chemostat volume of 250 mL. The
next morning, three lagoons (40 mL each, flow rate 100 mL/h) were started, with their waste
lines diverted through the in-line luminescence monitor. Lagoons were seeded with a
mixture containing 1010 pfu SP-T7Prom and 104 pfu SP-T7Spec and allowed to equilibrate for
4.5 h; during this time the lagoons received 0.1 M NaOH at 0.5 mL/h by syringe pump to
equilibrate the lagoons to the pH of the theophylline vehicle. After equilibration (t = 0 h),
lagoons received supplements delivered by syringe pump (flow rate 0.5 mL/h) consisting of
either 200 mM theophylline (to make 1 mM final concentration), 15 mM theophylline (to
make 75 μM final concentration), or vehicle only (0.1 M NaOH). After 16 h, the lagoon
receiving vehicle only was switched to receive 200 mM theophylline (1 mM final
concentration). At timepoints t = 0, 2, 4, 6, 8, 10, 12, and 20 h, 0.6 mL-samples were taken
from the lagoon, measured discretely for luminescence, and centrifuged to remove cells.
Supernatants were combined with an equal volume of 50% glycerol and stored in the
freezer.
Relative phage ratios in supernatant samples were assayed using a PCR and analytical
restriction digestion. 1 μL of each supernatant was added to a 20 μL qPCR reaction (iQ
SYBR Green Mastermix, Biorad) with primers JC1163 (5′-
GGAGTACGCTGCATCGAGATGCTCA-3′) and JC1488 (5′-
GTAGAAATCAGCCAGTACATCACAAGACTC-3′) and amplified by PCR with SYBR
Green fluorescence monitored following each amplification cycle. Samples were removed
individually from the PCR block after exceeding a pre-determined fluorescence threshold,
then placed on ice. Samples were quantitated again by SYBR Green fluorescence in a plate
reader, and approximately equal amounts of DNA from the reactions (normalized based on
the fluorescence readings) were added to restriction digestion reactions. The digestion
reactions used AvaII in buffer NEB4 and were performed according to manufacturer
instructions in 20-μL total volumes. Digestions were combined with 0.2 volumes of 5×
loading dye containing Orange G and xylene cyanol, and analyzed by agarose gel
electrophoresis (1% agarose, 0.5× TBE, 120V, 80 min). The electrophoresed gel was stained
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twith SYBR Gold (Invitrogen) and imaged on a Typhoon laser scanner (excitation 488,
emission 520/40 nm).
Continuous evolution of T3-selective RNA polymerases
A chemostat culture of S1030 cells carrying a DP encoding Ppsp-tet-gene III with a
mutagenesis cassette (pJC184d5) and an AP encoding PT3-gene III (pJC174f) was prepared
and equilibrated overnight at a flow rate of 400 mL/h in a chemostat volume of 250 mL. The
next morning, two lagoons (50 mL each, flow rate 100 mL/h) were started, with their waste
lines diverted through the in-line luminescence monitor.
Lagoons were seeded with 105 pfu of SP-T7WT. Lagoons received supplements delivered by
syringe pump (flow rate 1 mL/h) consisting of either 20 μM ATc (in 500 mM L-arabinose)
for lagoon 1 or vehicle alone (500 mM L-arabinose) for lagoon 2. At t = 12 h, lagoon 1's
supplement was changed to 2 μM ATc (in 500 mM L-arabinose). At t = 28 h, the first
chemostat was discontinued and both lagoons began receiving cells from a second
chemostat containing S1030 cells harboring an MP (pJC184), a PT3-gene III AP (pJC174f),
and a PT7-theophylline riboswitch-gene III-neg APneg (pJC173f-R5). Both lagoons received
500 mM L-arabinose. At t = 32 h, half of lagoon 1 was transferred to a new lagoon, lagoon
3. Lagoons 1 and 3 were brought to 40 mL total volumes with culture from the chemostat,
and lagoons were equilibrated for 40 min. Lagoons 1 and 2 then received 100 mM
theophylline (dissolved in 0.1 M NaOH, flow rate 1 mL/h), while lagoon 3 received vehicle
only (0.1 M NaOH). At t = 52 h, the second chemostat was discontinued and all lagoons
began receiving cells from a third chemostat containing S1030 cells harboring an MP
(pJC184), a reduced RBS PT3-gene III (pJC174k) and an enhanced RBS/copy number PT7-
gene III-neg APneg (pJC173g-SD8). All lagoon volumes were reduced to 40 mL each (flow
rate maintained at 100 mL/h) and were supplemented with 500 mM L-arabinose. At t = 70.5
h, lagoon volumes were reduced to 30 mL each, while the flow rate was maintained at 100
mL/h.
Periodically, 0.6 mL-samples were taken from the lagoon, measured discretely for
luminescence, and centrifuged to remove cells. Supernatants were combined with an equal
volume of 50% glycerol and stored in the freezer.
In vivo gene expression measurements on evolved RNA polymerases
Cells for luminescence assays were S1030 cells described above containing APs encoding
Ppsp-gene III (pJC184c-rrnB) and either PT7-luxAB (pJC173e4) or PT3-luxAB (pJC174e4).
Cells were grown to mid-log phase and 20-μL aliquots were distributed into a deep-well
plate. 10 μL of clonal phage aliquots were added to these wells and plates were incubated at
37 °C for 15 min. Wells were supplemented with 500 μL media, grown to mid-log phase,
and cells were transferred to a 96-well plate for luminescence measurement.
In vivo gene expression measurements on RNA polymerase forward mutants
Cells for luminescence assays were S1030 cells described above containing an expression
plasmid (EP) expressing a subcloned forward mutant T7 RNAP and APs encoding either
PT7-luxAB (pJC173e4) or PT3-luxAB (pJC174e4). Cultures were grown overnight and used
to seed 500-μL cultures in 96-well blocks that were grown to mid-log phase, after which
cells were transferred to a 96-well plate for luminescence measurement.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Overview of PACE with real-time monitoring
During PACE, host E. coli cells flow continuously into a fixed-volume vessel (a “lagoon”)
containing a population of filamentous bacteriophages that encode a library of evolving
proteins. The lagoon is continuously drained to a waste container after passing through an
in-line luminescence monitor that measures expression from a geneIII-luciferase cassette on
the AP. Dilution occurs faster than cell division but slower than phage replication. Each
phage carries a protein-encoding gene to be evolved instead of a phage gene (gene III) that
is required for infection. Phage encoding active library members trigger expression of gene
III on the AP in proportion to the desired activity and consequently produce infectious
progeny. Phage encoding less active library members produce fewer infectious progeny and
are lost by dilution.
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tFigure 2. Drift cassette enables ATc-dependent, activity-independent phage propagation
(a-c) Cells harboring APs with the indicated gene III-luxAB expression cassettes served as
recipients for phage propagation experiments using SP-T7WT. Data show representative
single measurements of phage concentrations (n = 1). (a) Using Ptet to induce gene III
expression with ATc prior to phage infection inhibits infection and results in minimal phage
propagation and low phage titers. (b) Using Ppsp to express gene III only after infection
takes place results in robust activity-independent phage propagation and high phage titers.
(c) Infection- and ATc-dependent gene III expression using Ppsp-tet enables robust, activity-
independent propagation. (d) Recipient cells carrying a drift plasmid (DP) and a PT7-gene III
AP were used to propagate a mixture of SP-T7WT (wild-type T7 RNAP, high activity) and
SP-T7Dead (D812G mutant T7 RNAP,14 no activity) at a ratio of 1:102 (“Mix” in (e)). (e) In
the absence of ATc, SP-T7WT (WT) is rapidly enriched over the inactive D812G mutant
polymerase (D) and a rapid increase in luciferase signal is observed. (f) At an intermediate
ATc concentration (150 ng/mL), SP-T7WT is enriched at a slower rate, concurrent with a
slower rise in luciferase signal. (g) At the highest ATc concentration (400 ng/mL), SP-T7WT
is not enriched and baseline luciferase signal is observed. After ending ATc supplementation
at t = 8 h, SP-T7WT is rapidly enriched and the luciferase signal rapidly rises.
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tFigure 3. Dominant negative pIII-neg is a potent inhibitor of phage propagation
(a) Recipient cells carrying a PT7-gene III AP and a PT3-gene III-neg APneg in which the
theophylline riboswitch controls gene III-neg expression were used to propagate a 1:106
mixture (“mix” in (b)) of SP-T7Spec (specific for PT7, “spec”) and SP-T7Prom (promiscuous
on both PT7 and PT3, “prom”), respectively. (b) At a high theophylline concentration (1000
μM), the promiscuous T7 RNAP SP is rapidly depleted and the specific T7 RNAP SP
quickly takes over the lagoon, concomitant with a sharp rise in luciferase signal from PT7.
(c) At an intermediate theophylline concentration, the promiscuous T7 RNAP SP slowly
washes out and is gradually replaced by the specific T7 RNAP SP. (d) In the absence of
theophylline, the promiscuous T7 RNAP SP propagates unhindered and the lagoon
maintains the starting ratio of the inoculated phage. Upon addition of high concentrations of
theophylline to this lagoon at t = 12 h, a rapid washout of the promiscuous T7 RNAP SP
takes place, with a rebound in luciferase signal consistent with specific T7 RNAP SP
enrichment. In (b)-(d), data show representative single measurements (n = 1).
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tFigure 4. Continuous evolution of T3-specific RNAP variants
PACE of T7 RNAP variants that recognize PT3 and reject PT7 was performed in three
contiguous stages of differing stringency (top). The PT3 and PT7 bars conceptually represent
amounts of gene III (red) or gene III-neg (blue) expressed for a given amount of polymerase
activity. At t = 0, host cells were E. coli containing the DP and a PT3-gene III AP. For the
first 12 hours, 200 ng/mL ATc was added to the lagoon to reduce selection stringency to
zero, enabling drift. At t = 12 h, the concentration of ATc was reduced to 20 ng/mL to
increase the stringency of positive selection. At t = 28 h, host cells were switched to E. coli
harboring an MP, a PT3-gene III AP and a riboswitch-controlled PT7-gene III-neg APneg. At
t = 32 h, 1 mM theophylline was added to increase negative selection stringency. At t = 52
h, host cells were switched to E. coli containing an MP, a reduced RBS PT3-gene III AP, and
an enhanced RBS/increased origin copy number PT7-gene III-neg APneg to further increase
negative and positive selection stringency. The in-line luminescence monitor was used
throughout to infer population fitness (center). Gene expression activities on the T7 and T3
promoters of randomly chosen clones from each stage were measured (bottom). Gene
expression data show mean values ± s.e. for two replicates. See Supplementary Figure 4 for
mutations present in each clone. N = no RNAP; T7 = wild-type T7 RNAP.
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tFigure 5. Analysis of evolved T7 RNAP mutations that confer PT3 specificity
(a) The gene expression activity in cells of T7 RNAP variants containing subsets of
mutations found in clones described in Fig. 5 are shown on the T7 promoter (blue bars) and
the T3 promoter (red bars). Gene expression data represent mean values ± s.e. for two
replicates. (b) Location of evolved mutations.21 The T7 promoter DNA is rendered as dark
blue and light purple surfaces, with light purple denoting nucleotide differences between the
T7 and T3 promoters. Cyan spheres identify evolved mutations that enable PT3 recognition.
Red spheres identify mutations that evolved during negative selection that contribute to
specific recognition of PT3 over PT7. Magenta spheres represent a conserved cluster of
mutually exclusive mutations evolved in clones following negative selection. The sequences
of the T7 and T3 promoters are shown at the bottom, with the differences in red.
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